Friday, April 24, 2026
Home Tags ADAP

Topic: ADAP

Stock Highlights: Adaptimmune Therapeutics (NASDAQ: ADAP)

Adaptimmune Therapeutics trades as part of the healthcare sector and is part of the biotechnology industry. The company CEO is James J. Noble. Adaptimmune Therapeutics along with its subsidiaries is a clinical-stage biopharmaceutical...

Latest News